spacer
spacer

PDBsum entry 5o5f

Go to PDB code: 
protein ligands links
DNA binding protein PDB id
5o5f

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
113 a.a.
Ligands
9LT
NO3 ×2
Waters ×223
PDB id:
5o5f
Name: DNA binding protein
Title: Crystal structure of the human brpf1 bromodomain in complex with bz038
Structure: Peregrin. Chain: a. Synonym: bromodomain and phd finger-containing protein 1,protein br140. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: brpf1, br140. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.30Å     R-factor:   0.176     R-free:   0.188
Authors: J.Zhu,A.Caflisch
Key ref: J.Zhu et al. (2018). Structure-based discovery of selective BRPF1 bromodomain inhibitors. Eur J Med Chem, 155, 337-352. PubMed id: 29902720 DOI: 10.1016/j.ejmech.2018.05.037
Date:
01-Jun-17     Release date:   13-Jun-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P55201  (BRPF1_HUMAN) -  Peregrin from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1214 a.a.
113 a.a.
Key:    PfamA domain  Secondary structure

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1016/j.ejmech.2018.05.037 Eur J Med Chem 155:337-352 (2018)
PubMed id: 29902720  
 
 
Structure-based discovery of selective BRPF1 bromodomain inhibitors.
J.Zhu, C.Zhou, A.Caflisch.
 
  ABSTRACT  
 
Bromodomain and plant homeodomain (PHD) finger containing protein 1 (BRPF1) is a member of subfamily IV of the human bromodomains. Experimental evidence suggests that BRPF1 is involved in leukemia. In a previous high-throughput docking campaign we identified several chemotypes targeting the BRPF1 bromodomain. Here, pharmacophore searches using the binding modes of two of these chemotypes resulted in two new series of ligands of the BRPF1 bromodomain. The 2,3-dioxo-quinoxaline 21 exhibits a 2-μM affinity for the BRPF1 bromodomain in two different competition binding assays, and more than 100-fold selectivity for BRPF1 against other members of subfamily IV and representatives of other subfamilies. Cellular activity is confirmed by a viability assay in a leukemia cell line. Isothermal titration calorimetry measurements reveal enthalpy-driven binding for compounds 21, 26 (KD = 3 μM), and the 2,4-dimethyl-oxazole derivative 42 (KD = 10 μM). Multiple molecular dynamics simulations and a dozen co-crystal structures at high resolution provide useful information for further optimization of affinity for the BRPF1 bromodomain.
 

 

spacer

spacer